Voso, M., Fabiani, E., Piciocchi, A., Matteucci, C., Brandimarte, L., Finelli, C., et al. (2011). Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. LEUKEMIA, 25(12), 1910-1913 [10.1038/leu.2011.170].

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine

POGLIANI, ENRICO MARIA;GRECO, CAROLINA MAGDALEN;
2011

Articolo in rivista - Articolo scientifico
Antimetabolites, Antineoplastic; Male; Prognosis; Retrospective Studies; Azacitidine; Survival Rate; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Mutation; Female; Risk Factors; DNA-Binding Proteins; Humans; DNA Methylation; Proto-Oncogene Proteins; Aged; Adult; Myelodysplastic Syndromes
English
2011
25
12
1910
1913
reserved
Voso, M., Fabiani, E., Piciocchi, A., Matteucci, C., Brandimarte, L., Finelli, C., et al. (2011). Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. LEUKEMIA, 25(12), 1910-1913 [10.1038/leu.2011.170].
File in questo prodotto:
File Dimensione Formato  
leu2011170a.pdf

Solo gestori archivio

Dimensione 231.94 kB
Formato Unknown
231.94 kB Unknown   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/28871
Citazioni
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 34
Social impact